GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,856,000 | +300.9% | 31,611 | +113.3% | 0.00% | – |
| Q4 2020 | $1,710,000 | -8.4% | 14,821 | -22.7% | 0.00% | – |
| Q3 2020 | $1,867,000 | -22.9% | 19,175 | -2.9% | 0.00% | – |
| Q2 2020 | $2,422,000 | +26.5% | 19,738 | -9.7% | 0.00% | – |
| Q1 2020 | $1,914,000 | +96.1% | 21,855 | +134.2% | 0.00% | – |
| Q4 2019 | $976,000 | -2.4% | 9,333 | +7.3% | 0.00% | – |
| Q3 2019 | $1,000,000 | -34.1% | 8,694 | -1.3% | 0.00% | – |
| Q2 2019 | $1,518,000 | +7.7% | 8,806 | +5.3% | 0.00% | – |
| Q1 2019 | $1,409,000 | +70.0% | 8,359 | -1.8% | 0.00% | – |
| Q4 2018 | $829,000 | +262.0% | 8,510 | +277.4% | 0.00% | – |
| Q3 2017 | $229,000 | +8.0% | 2,255 | +6.7% | 0.00% | – |
| Q2 2017 | $212,000 | -70.6% | 2,114 | -79.6% | 0.00% | – |
| Q4 2015 | $721,000 | – | 10,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
| VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
| Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
| United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
| PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
| Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
| CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
| Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |